Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
about
Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insightsHepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver ResectionDes-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.MRI features of hepatocellular carcinoma related to biologic behaviorLiver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experienceA20 inhibits the motility of HCC cells induced by TNF-αA role for CD81 and hepatitis C virus in hepatoma mobility.Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.Liver Transplantation for HCC: A Review.Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation.Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging: A comparison of mean and minimum apparent diffusion coefficient values.Inappropriate inferences from registry data: Pitfalls of inaccurate data handling?Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database.Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies.Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma.Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging.Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
P2860
Q26799928-222B896D-8656-4B6A-A065-A7D819B08137Q33755269-5191575D-7F86-4F46-BE46-3C4FA4AACF9FQ35147875-1E440EC7-9F9E-4E3D-8CDC-3C80C3503D40Q35619951-0681696F-D9AA-426C-8A4A-1FE2ECD3E106Q36702287-9F84DA8D-A436-4687-9F00-358044FD6C09Q36728731-BDB04180-C287-467C-B7EF-C6B94D8AF6B3Q37015289-F8299F89-2C80-4A92-8A3B-519713EB5178Q37046703-18C231D1-6EC7-44DD-A66A-32EE93BBCFFDQ37673172-4DA86427-4145-4DDA-94F7-A175D904D1A6Q37952030-6CE2B4FE-7636-411C-9B27-E1D16E8DD656Q38078347-42BE1341-BA97-44D7-8A43-6E6711705AC6Q38237510-961E46C6-F9E9-4AF3-8F20-CE175BA00F61Q38795885-0838C2F6-AE5A-4A3B-9CC1-0691CD93E25DQ38824638-AB3069F3-F1CB-42A6-8636-52AB609DE9DBQ41022854-E92C3798-9E2E-42A4-8254-90DA90F5304DQ41521422-6B1F4FB0-71DE-4077-893B-F427538F78CAQ44073825-552A9379-E744-4000-A71A-3356F1563DC3Q44119630-6387ABD1-FF47-4C8D-9983-5EDCA8F2C96AQ46171460-687F35CC-21DD-45BE-AF5E-B260D91FCE7BQ46456307-33B6327B-AF97-4951-9D10-056011DE04AAQ47139481-227E7B05-22F7-41B6-A09C-A24699159449Q47964964-AFF58FE1-085A-4642-B352-B915F6369061Q50659230-814F5CAA-D734-4406-863A-41B416F15AADQ53049436-1C039906-65BA-4C9A-9A64-B95B4D2CA4A4Q53084104-5DD34304-7207-48D1-B3D6-56188CABE5DEQ53339547-D41A2FC4-5F2E-4E44-B659-6A9DB59AF358Q53369248-E49C5862-B4C1-4530-8309-EA57489DC545Q54978814-D52FE801-6DAF-4613-A19B-DE2AF7499710Q55384238-11042C7F-2F2E-4F54-8B8F-43168118F8D8Q58707841-C20AC070-D388-4CC8-99EA-FFB953A2D7F3
P2860
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@en
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@nl
type
label
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@en
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@nl
prefLabel
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@en
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@nl
P2093
P2860
P356
P1476
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
@en
P2093
Annette S H Gouw
Charles Balabaud
Hironori Kusano
Masamichi Kojiro
Satoru Todo
Takafumi Ichida
P2860
P304
P356
10.1002/LT.22368
P478
17 Suppl 2
P577
2011-10-01T00:00:00Z